Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2025 Earnings Call Transcript October 22, 2025
Viking Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.81 EPS, expectations were $-0.7.
Operator: Welcome to the Viking Therapeutics Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today, October 22, 2025. I would now like to turn the conference over to Viking’s Manager of Investor Relations,...
